Acquisition of CG USA Secures U.S. Production Base
Expansion into Canada Planned for Second Half, Accelerating North American Market Strategy

Pharmaresearch is strengthening its capabilities to respond to the North American market by acquiring a U.S. cosmetics manufacturer.


On July 1, Pharmaresearch announced that it had signed an acquisition agreement with CG USA, a local original equipment manufacturer (OEM) and original design manufacturer (ODM) cosmetics company, on June 30 (local time) in the United States. This move aims to address the rising demand for Rejuran Cosmetic products and establish a stable supply system in the U.S. market. The scale of the acquisition will not be disclosed as agreed by both parties.


Pharmaresearch and CG USA officials took a group photo in the United States on the 30th of last month (local time) to commemorate the signing of the acquisition agreement. Pharmaresearch

Pharmaresearch and CG USA officials took a group photo in the United States on the 30th of last month (local time) to commemorate the signing of the acquisition agreement. Pharmaresearch

View original image

CG USA is a cosmetics manufacturer based in California, equipped with production facilities capable of handling product planning, formulation development, manufacturing, filling, packaging, and quality control. In addition to possessing a cosmetics manufacturing license, the company operates FDA-registered facilities and maintains a quality management system in compliance with current Good Manufacturing Practice (cGMP) standards, enabling it to produce over-the-counter (OTC) products.


Pharmaresearch explained that the decision to acquire CG USA was made to ensure a stable response to the expanding demand for Rejuran Cosmetic products, particularly through channels such as Sephora and Amazon.


Until now, the company had supplied products manufactured in Korea to the U.S. market. However, by securing a local production base through the acquisition of CG USA, Pharmaresearch is set to enhance supply chain efficiency and market responsiveness across production, logistics, and distribution. The company plans to strengthen supply stability within the North American market and actively pursue a localization strategy in the Americas to expand into markets such as Canada and other regions in North and South America.


Rejuran Cosmetic is reinforcing its online and offline distribution networks in the United States, focusing on channels such as Sephora and Amazon. The brand is also scheduled to enter the Canadian market in the second half of this year.



Jihoon Son, CEO of Pharmaresearch, stated, "The acquisition of CG USA is a strategic decision to strengthen supply stability and establish a foundation for business expansion in the North American market. Based on local production capabilities and quality infrastructure, we will continue to enhance the competitiveness of our global derma-cosmetics business."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing